Han Kun advised Cenova Bioventure in its investment in a medical technology company
2011-02-25
Shanghai Cenova Bioventure Co., Ltd. completed its equity investment in a medical technology company.
Han Kun advised Shanghai Cenova Bioventure Co., Ltd., a life science-specific RMB fund, in this investment transaction.
Han Kun primarily assisted in the preparation of the investment documents, and the legal due diligence review on the target company.
The leading lawyers involved in this deal are Yijun CHAO, Anita SUN, Li ZHANG and Xu LIU.